Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes

BACKGROUND: Resistance to ESAs (erythropoietin stimulating agents) is highly prevalent in hemodialysis patients with diabetes and associated with an increased mortality. The aim of this study was to identify predictors for ESA resistance and to develop a prediction model for the risk stratification...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Andreas, Schneider, Markus P, Scharnagl, Hubert, Jardine, Alan G, Wanner, Christoph, Drechsler, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614514/
https://www.ncbi.nlm.nih.gov/pubmed/23521816
http://dx.doi.org/10.1186/1471-2369-14-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614514/
https://www.ncbi.nlm.nih.gov/pubmed/23521816
http://dx.doi.org/10.1186/1471-2369-14-67

Ejemplares similares